Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Chiara Cecere

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|December 23, 2020
How to sequence treatment in relapsed ovarian cancerSandro Pignata, Sabrina Chiara Cecere
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2025
Controversies in the management of grade 1 and 2 endometrioid carcinoma of the ovary and uterusAlice Bergamini, Sabrina Chiara Cecere, Michele Bartoletti, et al.
Expert Opinion on Drug Safety|September 5, 2023
Safety of PARP inhibitors as maintenance therapy in ovarian cancerSabrina Chiara Cecere, Chiara Casartelli, Miriam Forte, et al.
Cancer|January 23, 2020
Treatment of recurrent epithelial ovarian cancerSandro Pignata, Carmela Pisano, Marilena Di Napoli, et al.
Chinese Journal of Cancer|January 6, 2015
Ovarian cancer standard of care: are there real alternatives?Chiara Della Pepa, Giuseppe Tonini, Carmela Pisano, et al.
Cancer Treatment Reviews|January 10, 2015
Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategyChiara Della Pepa, Giuseppe Tonini, Daniele Santini, et al.
Journal of Drug Delivery|April 12, 2013
Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancerCarmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, et al.
Expert Opinion on Biological Therapy|January 7, 2014
New biological treatments for gynecological tumors: focus on angiogenesisGennaro Daniele, Massimo Di Maio, Maria Carmela Piccirillo, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Analytical Cellular Pathology (Amsterdam)|January 13, 2017
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based ChemotherapyErnesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|December 23, 2020
How to sequence treatment in relapsed ovarian cancerSandro Pignata, Sabrina Chiara Cecere
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2025
Controversies in the management of grade 1 and 2 endometrioid carcinoma of the ovary and uterusAlice Bergamini, Sabrina Chiara Cecere, Michele Bartoletti, et al.
Expert Opinion on Drug Safety|September 5, 2023
Safety of PARP inhibitors as maintenance therapy in ovarian cancerSabrina Chiara Cecere, Chiara Casartelli, Miriam Forte, et al.
Cancer|January 23, 2020
Treatment of recurrent epithelial ovarian cancerSandro Pignata, Carmela Pisano, Marilena Di Napoli, et al.
Chinese Journal of Cancer|January 6, 2015
Ovarian cancer standard of care: are there real alternatives?Chiara Della Pepa, Giuseppe Tonini, Carmela Pisano, et al.
Cancer Treatment Reviews|January 10, 2015
Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategyChiara Della Pepa, Giuseppe Tonini, Daniele Santini, et al.
Journal of Drug Delivery|April 12, 2013
Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancerCarmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, et al.
Expert Opinion on Biological Therapy|January 7, 2014
New biological treatments for gynecological tumors: focus on angiogenesisGennaro Daniele, Massimo Di Maio, Maria Carmela Piccirillo, et al.
Biomolecules|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Analytical Cellular Pathology (Amsterdam)|January 13, 2017
Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based ChemotherapyErnesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, et al.
Pageof 6